Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis

<div>A summary of the treatment history, relapses, and treatment of all 11 patients in the study. Initial onset of ON was not included in the determination of number of relapses in the study. AQP4: anti-aquaporin4 antibody; MOG: anti-myelin oligodendrocyte glycoprotein.</div>

Journal of Ophthalmology

fig1

Figure 1

Figure 1: Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis 

Figure 1 | Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis 